# The Pharmacokinetics and Pharmacodynamics of Oral and Vaporized Cannabidiol

> **NCT03164512** · PHASE1 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 19 (actual)

## Conditions studied

- Cannabidiol Pharmacokinetics

## Interventions

- **DRUG:** Oral or vaporized cannabidiol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03164512
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-01
- **Primary completion:** 2019-08-29
- **Final completion:** 2020-01-22
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2020-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03164512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03164512, "The Pharmacokinetics and Pharmacodynamics of Oral and Vaporized Cannabidiol". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03164512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*